D&C biotechnology Inc.

DNC Biotechnology Secures ₩500 Million in Seed Funding

  • 2023.03.31

D&C Biotechnology Co., Ltd. (CEO Park Sung-soo), a developer of next-generation urine diagnostic solutions such as deep-tech-based urinalysis precision analyzers and urine test kits, announced that it has raised ₩500 million in funding. The investment was led by Low Partners Co., Ltd., Mirae Science and Technology Holdings Co., Ltd., and History Venture Investment.

 

The urinalysis precision analyzer and urine test kit developed by D&C Biotechnology address the complexities and time-consuming nature of conventional urine testing methods. Their innovative “One-Step” urine analysis and diagnostic system simplifies the process by enabling immediate analysis and result transmission after sample collection, making it both efficient and user-friendly.

 

CEO Park Sung-soo of D&C Biotechnology has secured one patent registration, five patent applications, two PCT applications, and four trademark and design applications related to their next-generation urine analyzer. The company has also received medical device certification and manufacturing permits from the Ministry of Food and Drug Safety in Korea. Additionally, they have established distribution networks through MOUs with various medical institutions and device companies and are preparing for FDA and CE certifications for global expansion.

 

Recognized for its expertise, D&C Biotechnology successfully raised ₩500 million in seed funding. Low Partners, Mirae Science and Technology Holdings, and History Venture Investment expressed their confidence in the company, stating, “The conventional urine testing process has been cumbersome and prone to issues such as sample contamination, leading to unclear diagnostic results. D&C Biotechnology’s innovative in-vitro diagnostic devices provide a breakthrough solution. We were impressed by the capabilities of CEO Park Sung-soo and his team and are confident that D&C Biotechnology will emerge as a paradigm changer in the in-vitro diagnostic device industry.”

 

CEO Park Sung-soo remarked, “Our company has been dedicated to advancing in-vitro diagnostic devices for early disease detection and treatment. With this investment, we aim to take a significant step forward, ensuring the safety and convenience of medical professionals worldwide while enhancing the accuracy and reliability of diagnostic results for patients suffering from various diseases.”

© 2025 D&C Biotechnology Inc. All Rights Reserved.

위로 스크롤
Close

Data Privacy Notice (Privacy Policy)

Article 1 (Consent to Collection of Personal Information) D&C Biotechnology has set up a procedure whereby users can click the “Agree” or “Cancel” button for the content of D&C Biotechnology’s Privacy Policy or Terms of Use. By clicking the “Agree” button, you are deemed to have consented to the collection of personal information.

 

Article 2 (Personal Information Collection Items) The personal information items processed for consultation through online inquiries are as follows. Collection items: Name, Email, Phone number

 

Article 3 (Purpose of Use of Personal Information) D&C Biotechnology does not disclose users’ personal information without prior consent and collects personal information for smooth customer consultation and provision of various services as follows. All information will not be used for purposes other than those stated above, and prior consent will be obtained if the scope of information collected, purpose of use, or usage changes. Company name, name: Confirmation of identity for product consultation Email, Phone number: Delivery of product consultation and event-related notifications, provision of new service and new product information (DM, SMS, email, etc.) Users can refuse consent to the collection/use of personal information. However, if you refuse consent, online consultation is not possible and you may be restricted in using the service and receiving benefits.

 

Article 4 (Retention and Use Period of Personal Information) In principle, after the purpose of collecting and using personal information is achieved, the information is destroyed without delay. However, if there is a need for preservation in accordance with the provisions of related laws such as the Commercial Law, the Consumer Protection Act in E-commerce, etc., the company keeps the information for a certain period specified in related laws. In this case, the company uses the information stored only for the purpose of its preservation, and the preservation period is as follows. Record of contract or subscription withdrawal: 5 years (Consumer Protection Act in E-commerce, etc.) Record of consumer complaints or dispute resolution: 3 years (Consumer Protection Act in E-commerce, etc.) Record of collection/processing and use of credit information: 3 years (Act on the Use and Protection of Credit Information)

 

The company securely processes valuable user personal information and destroys personal information in the following ways to prevent leaks. Personal information printed on paper is destroyed by shredding or incineration. Personal information stored in electronic file format is deleted using a technical method that cannot reproduce the record

Close

Unauthorised Email Collection is Prohibited

[Unauthorised Email Collection is Prohibited]

 

The unauthorized collection of email addresses posted on this website, through email collection programs or any other technical devices, is strictly prohibited. This includes collecting email addresses without the prior consent of the website operator or administrator. Such unauthorized collection of email addresses is illegal. Violators will be subject to criminal punishment under

 

Article 50-2 of the Act on Promotion of Information and Communications Network Utilization and Information Protection.

 

Article 50-2 of the Act on Promotion of Information and Communications Network Utilization and Information Protection (Prohibition of Unauthorized Collection of E-mail Addresses)

 

  1. No one shall use a program or any other technical device to automatically collect email addresses from the internet website, without the prior consent of the website operator or administrator.
  2. No one shall sell or distribute email addresses collected in violation of paragraph 1.
  3. No one shall knowingly use email addresses, collected, sold or distributed in violation of paragraphs 1 and 2, for the purpose of transmitting information.